New SPAC sub­mits plans for $130M IPO, as an­oth­er rais­es $60M

Two new biotech SPACs have come to town — and one of them has gone pub­lic.

Keen Vi­sion Ac­qui­si­tion Corp. an­nounced its for­ma­tion via SEC fil­ing on Thurs­day, where it will look to raise $130 mil­lion through its IPO. The cur­rent plan is to sell 13 mil­lion shares at $10 a piece.

The fil­ing says that while the SPAC has not iden­ti­fied a com­pa­ny to com­bine with, the SPAC is look­ing at mul­ti­ple in­dus­tries, in­clud­ing biotech, con­sumer goods or agri­cul­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER